Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study

• Jian Chu,
• Lillian Tung,
• Issam Atallah,
• Changli Wei,
• Melody Cobleigh,
• Ruta Rao,
• Steven B. Feinstein,
• Lydia Usha,
• Kathrin Banach,
• Jochen Reiser,
• Tochukwu M. Okwuosa

Affiliations

Jian Chu

Department of Internal Medicine, Rush University Medical Center

Lillian Tung

Department of Internal Medicine, Rush University Medical Center

Issam Atallah

Department of Internal Medicine, Division of Cardiology, Saint Louis University Hospital

Changli Wei

Department of Internal Medicine, Rush University Medical Center

Melody Cobleigh

Department of Internal Medicine, Section of Hematology/Oncology, Rush University Medical Center

Ruta Rao

Department of Internal Medicine, Section of Hematology/Oncology, Rush University Medical Center

Steven B. Feinstein

Department of Internal Medicine, Division of Cardiology, Rush University Medical Center

Lydia Usha

Department of Internal Medicine, Section of Hematology/Oncology, Rush University Medical Center

Kathrin Banach

Department of Internal Medicine, Division of Cardiology, Rush University Medical Center

Jochen Reiser

Department of Internal Medicine, Rush University Medical Center

Tochukwu M. Okwuosa

Department of Internal Medicine, Division of Cardiology, Rush University Medical Center